{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:58:30Z","timestamp":1789415910359,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04039-2","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:29:30Z","timestamp":1744212570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Presumed reactivation of herpes simplex virus-associated endothelial keratitis after treatment with topical interferon-\u03b1 2b for ocular surface squamous neoplasia"],"prefix":"10.1186","volume":"25","author":[{"given":"Sepehr","family":"Feizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"11","key":"4039_CR1","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00417-013-2450-0","volume":"251","author":"BH - Kim","year":"2013","unstructured":"- Kim BH, Kim MK, Wee WR, Oh JY. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Graefes Arch Clin Exp Ophthalmol. 2013;251(11):2569\u201373.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"4039_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41433-023-02434-x","volume":"37","author":"D - Monroy","year":"2023","unstructured":"- Monroy D, Serrano A, Galor A, Karp CL. Medical treatment for ocular surface squamous neoplasia. Eye (Lond). 2023;37(5):885\u201393.","journal-title":"Eye (Lond)"},{"issue":"5","key":"4039_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ophtha.2013.11.017","volume":"121","author":"AA - Nanji","year":"2014","unstructured":"- Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Ophthalmology. 2014;121(5):994\u20131000.","journal-title":"Ophthalmology"},{"issue":"10","key":"4039_CR4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.ophtha.2012.04.022","volume":"119","author":"A - Galor","year":"2012","unstructured":"- Galor A, Karp CL, Oellers P, Kao AA, Abdelaziz A, Feuer W, Dubovy SR. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology. 2012;119(10):1974\u201381.","journal-title":"Ophthalmology"},{"issue":"5","key":"4039_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/jir.2018.0125","volume":"39","author":"N - Lewczuk","year":"2019","unstructured":"- Lewczuk N, Zdebik A, Bogus\u0142awska J. Interferon alpha 2a and 2b in ophthalmology: a review. J Interferon Cytokine Res. 2019;39(5):259\u201372.","journal-title":"J Interferon Cytokine Res"},{"key":"4039_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40662-019-0150-5","volume":"6","author":"G - Al Bayyat","year":"2019","unstructured":"- Al Bayyat G, Arreaza-Kaufman D, Venkateswaran N, Galor A, Karp CL. Update on pharmacotherapy for ocular surface squamous neoplasia. Eye Vis (Lond). 2019;6:24.","journal-title":"Eye Vis (Lond)"},{"issue":"5","key":"4039_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.eye.6700113","volume":"16","author":"MV - Parulekar","year":"2002","unstructured":"- Parulekar MV, Khooshabeh R, Graham C. Topical and intralesional interferon therapy for recurrent lacrimal papilloma. Eye (Lond). 2002;16(5):649\u201351.","journal-title":"Eye (Lond)"},{"issue":"8","key":"4039_CR8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/bjo.2006.107482","volume":"91","author":"AJ - Aldave","year":"2007","unstructured":"- Aldave AJ, Nguyen A. Ocular surface toxicity associated with topical interferon alpha-2b. Br J Ophthalmol. 2007;91(8):1087\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"4039_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/ICO.0000000000001547","volume":"37","author":"GA - Lee","year":"2018","unstructured":"- Lee GA, Hess L, Glasson WJ, Whitehead K. Topical interferon alpha-2b induced reactive lymphoid hyperplasia masquerading as orbital extension of ocular surface squamous neoplasia. Cornea. 2018;37(6):796\u20138.","journal-title":"Cornea"},{"issue":"3","key":"4039_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1542-0124(12)70614-6","volume":"5","author":"S - Guess","year":"2007","unstructured":"- Guess S, Stone DU, Chodosh J. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007;5(3):240\u201350.","journal-title":"Ocul Surf"},{"issue":"1","key":"4039_CR11","first-page":"CD002898","volume":"1","author":"KR - Wilhelmus","year":"2015","unstructured":"- Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;1(1):CD002898.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"4039_CR12","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1136\/bjo.85.8.1007a","volume":"85","author":"P - Ekatomatis","year":"2001","unstructured":"- Ekatomatis P. Herpes simplex dendritic keratitis after treatment with Latanoprost for primary open angle glaucoma. Br J Ophthalmol. 2001;85(8):1008\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4039_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00003226-200403000-00004","volume":"23","author":"T - Deai","year":"2004","unstructured":"- Deai T, Fukuda M, Hibino T, Higaki S, Hayashi K, Shimomura Y. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications. Cornea. 2004;23(2):125\u20138.","journal-title":"Cornea"},{"issue":"9","key":"4039_CR14","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.4049\/jimmunol.149.9.3023","volume":"149","author":"RL - Hendricks","year":"1992","unstructured":"- Hendricks RL, Tumpey TM, Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the Corneas of HSV-1-infected mice. J Immunol. 1992;149(9):3023\u20138.","journal-title":"J Immunol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04039-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:04:52Z","timestamp":1744247092000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04039-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"Written informed consent for the use of personal details and associated images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}